Atlas Trials

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Lymphoma or Leukemia

Clinical trial NCT00005786 · TERMINATED

Trial details

NCT number
NCT00005786
Sponsor
National Cancer Institute (NCI)
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaProlymphocytic LeukemiaRecurrent Adult Diffuse Small Cleaved Cell LymphomaRecurrent Grade 1 Follicular LymphomaRecurrent Grade 2 Follicular LymphomaRecurrent Marginal Zone LymphomaRecurrent Small Lymphocytic LymphomaRefractory Chronic Lymphocytic LeukemiaSplenic Marginal Zone LymphomaWaldenström Macroglobulinemia
Start date
2001-01-01
Primary completion
2004-11-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.